← Back
$VTYX All transactions

Ventyx Biosciences, Inc.

J

$ Value

$0

Shares

694,718

Price

$0

Filed

Mar 3

Insider

Name

Subramaniam Somu

Title

CIK

0001508910

Roles

Director

Transaction Details

Transaction Date

2026-02-27

Code

J

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

3,337,495

Footnotes

474,632 shares held by NSV Partners III, L.P. and 220,086 shares held by New Science Ventures, LLC, respectively, were distributed on a pro rata basis, for no consideration. | NSV Partners III, L.P. is the general partner of NSV Investments I, L.P. The reporting person is the majority member and managing member of NSV Partners III GP, LLC, which is the general partner of NSV Partners III, L.P., and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, L.P. is general partner. The reporting person is the majority member and managing member of NSV Partners II, LLC. The reporting person is the majority member and managing member of New Science Ventures, LLC. The reporting person disclaims beneficial ownership over the shares owned by each of the NSV Funds (as defined below), except to the extent of his pecuniary interest therein. | The shares beneficially owned by the reporting person consists of: (i) 1,807,664 shares owned by NSV Investments I, L.P., (ii) 906,974 shares owned by NSV Partners III, L.P., (iii) 408,520 shares owned by NSV Partners II, LLC, and (iv) 214,337 shares owned by New Science Ventures, LLC (collectively, the "NSV Funds").

Filing Info

Accession No.

0001508910-26-000002

Form Type

4

Issuer CIK

0001851194

Subramaniam Somu's History

Date Ticker Type Value
2026-03-04 VTYX D
2026-03-04 VTYX D
2026-03-04 VTYX D
2026-03-04 VTYX D
2026-03-04 VTYX D
2026-03-04 VTYX D
2026-02-27 VTYX J $0
2025-06-05 VTYX A $0

Other Insiders at VTYX (90d)

Insider Bought Sold Last
Subramaniam Somu 2026-03-04
HULME ALLISON 2026-03-04
GUJRATHI SHEILA 2026-03-04
White William Richard 2026-03-04
Cadoret-Manier Onaiza 2026-03-04
Moore Matthew Richard
Chief Operating Officer
2026-03-04
Nuss John
CHIEF SCIENTIFIC OFFICER
2026-03-04
Mohan Raju
CEO AND PRESIDENT
2026-03-04
Forman Mark S
Chief Medical Officer
2026-03-04
Gonzales Roy
Senior VP, Finance
2026-03-04